Cargando…

Immune Thrombocytopenia Could be an Independent Clinical Phenotype of Antiphospholipid Syndrome: A Prospective Cohort Study

BACKGROUND: Patients with persistent positive antiphospholipid antibodies (aPLs) and immune thrombocytopenia (ITP) hardly develop thrombosis but share many similar characteristics with antiphospholipid syndrome (APS). METHODS: This is a prospective cohort study consecutively enrolling thrombocytopen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Yu, Jiang, Hui, Zhao, Yongqiang, Zhao, Jiuliang, Li, Mengtao, Zeng, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140258/ https://www.ncbi.nlm.nih.gov/pubmed/36807880 http://dx.doi.org/10.1007/s40744-023-00538-0

Ejemplares similares

Recurrent Non-stroke Central Neurologic Manifestations in Primary Antiphospholipid Syndrome
por: You, Hanxiao, et al.
Publicado: (2022)

Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort
por: Zhao, Yuan, et al.
Publicado: (2023)

Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population
por: Hu, Chaojun, et al.
Publicado: (2020)

Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients
por: Li, Siting, et al.
Publicado: (2023)

Detection of IgA Antiphospholipid Antibodies Does not Improve Thrombotic Antiphospholipid Syndrome Classification: A two-Center Study
por: Su, Zhenzhen, et al.
Publicado: (2022)

Evaluation of the Diagnostic Value of Non-criteria Antibodies for Antiphospholipid Syndrome Patients in a Chinese Cohort
por: Hu, Chaojun, et al.
Publicado: (2021)

Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China
por: Zhou, Yangzhong, et al.
Publicado: (2023)

Comparison of Different Test Systems for the Detection of Antiphospholipid Antibodies in a Chinese Cohort
por: Hu, Chaojun, et al.
Publicado: (2021)

Early Initiation of Anticoagulation Improves the Long-Term Prognosis in Patients With Antiphospholipid Syndrome Associated Portal Vein Thrombosis
por: You, Hanxiao, et al.
Publicado: (2021)

Extra-criteria clinical manifestations of antiphospholipid antibody should not be ignored
por: Huang, Can, et al.
Publicado: (2022)

Sex Differences in Clinical Characteristics and Prognosis in Primary Thrombotic Antiphospholipid Syndrome
por: Huang, Yongfa, et al.
Publicado: (2022)

Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome
por: Zhao, Yuan, et al.
Publicado: (2023)

Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study
por: Qi, Wanting, et al.
Publicado: (2022)

Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?
por: Tomasello, Riccardo, et al.
Publicado: (2021)

Right Atrial Thrombosis in Antiphospholipid Syndrome with Secondary Immune Thrombocytopenia
por: Voigtlaender, Minna, et al.
Publicado: (2015)

New insights into the pathogenesis and management of rheumatoid arthritis
por: Jin, Shangyi, et al.
Publicado: (2022)

A rare case of pediatric immune thrombocytopenia with secondary antiphospholipid syndrome in Korea
por: Mun, Eun Ji, et al.
Publicado: (2022)

Chronic Thromboembolic Pulmonary Hypertension and Antiphospholipid Syndrome with Immune Thrombocytopenia: A Case Report
por: Skride, Andris, et al.
Publicado: (2018)

The Challenges and Future Perspective for the Management of Systemic Lupus Erythematosus in China: A Concise Annual Report of 2020
por: Tian, Xinping, et al.
Publicado: (2022)

Thrombocytopenia Is an Independent Risk Factor for the Prognosis of Thrombotic Microangiopathy in Chinese Patients With Systemic Lupus Erythematosus
por: Yang, Fan, et al.
Publicado: (2021)

Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndrome
por: Vreede, Andrew P., et al.
Publicado: (2019)

Clinical Implications of Elevated Antiphospholipid Antibodies in Adult Patients with Primary Immune Thrombocytopenia
por: Yang, Young-Joon, et al.
Publicado: (2011)

Plasma Exchange in a Patient with Immune Thrombocytopenia Associated with Antiphospholipid Syndrome Hospitalized for COVID-19
por: Boggio, Federico, et al.
Publicado: (2022)

Activation of Toll-Like Receptor 7 Signaling Pathway in Primary Sjögren's Syndrome-Associated Thrombocytopenia
por: Zhang, Shuo, et al.
Publicado: (2021)

The efficacy of Mycophenolate mofetil for the treatment of Chinese Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2016)

Antiphospholipid Syndrome in a Pregnant Female Presenting with Severe Thrombocytopenia and Bleeding
por: Mahajan, Kunal, et al.
Publicado: (2015)

Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia
por: Freire de Carvalho, Jozélio, et al.
Publicado: (2021)

Clinical characteristics and prognosis of patients with isolated thrombotic vs. obstetric antiphospholipid syndrome: a prospective cohort study
por: Jiang, Hui, et al.
Publicado: (2021)

Curative resolution of chronic thromboembolic pulmonary hypertension with pulmonary thromboendarterectomy in primary antiphospholipid syndrome: A case report
por: Li, Can, et al.
Publicado: (2018)

Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?
por: Parodi, Aurora, et al.
Publicado: (2020)

Thrombocytopenia in a cohort of primary and secondary antiphospholipid syndrome patients: Relation to clinical, laboratory manifestations and damage index
por: Gamal, Sherif, et al.
Publicado: (2022)

A modified regimen of low-dose rituximab therapy for patients with refractory immune thrombocytopenia associated with systemic lupus erythematosus
por: Zhang, Shuo, et al.
Publicado: (2021)

Catastrophic antiphospholipid syndrome in lupus-associated immune thrombocytopenia treated with eltrombopag A case series and literature review
por: Garra, Wakar, et al.
Publicado: (2023)

Thrombocytopenia in the first trimester predicts adverse pregnancy outcomes in obstetric antiphospholipid syndrome
por: Jin, Jiayang, et al.
Publicado: (2022)

Cause of death in Chinese Takayasu arteritis patients
por: Li, Jing, et al.
Publicado: (2016)

Chinese SLE Treatment and Research Group (CSTAR) Registry 2009–2019: Major Clinical Characteristics of Chinese Patients with Systemic Lupus Erythematosus
por: Li, Mengtao, et al.
Publicado: (2021)

RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China
por: Huang, Can, et al.
Publicado: (2022)

2022 Chinese guideline for the management of pregnancy and reproduction in systemic lupus erythematosus
por: Tian, Xinping, et al.
Publicado: (2023)

Amniotic fluid antiphospholipid antibodies: potential role in antiphospholipid syndrome-independent aberrant implantation process
por: Bruno, Valentina, et al.
Publicado: (2019)

Factors Associated With Renal Involvement in Primary Sjögren's Syndrome: A Meta-Analysis
por: Hong, Ruping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_htsmndoq10pnu1ra6s0604klkr